Overview

  • Product nameNNC 05-2090
  • Description
    GABA uptake inhibitor
  • Biological descriptionGABA uptake inhibitor, selective for the BGT-1 transporter (Ki values are 1.4, 19, 41 and 15 μM at BGT-1, GAT-1, GAT-2 and GAT-3 respectively). Also active at α1- and D2-receptors (IC50 values are 266 and 1632 nM respectively). Anti-convulsant in vivo.
  • Purity> 99%

Properties

    References for NNC 05-2090 (ab120317)

    This product has been referenced in:
    • Thomsen C  et al. 1-(3-(9H-carbazol-9-yl)-1-propyl)-4-(2-methoxyphenyl)-4-piperidinol, a novel subtype selective inhibitor of the mouse type II GABA-transporter. Br J Pharmacol 120:983-5 (1997). Read more (PubMed: 9134205) »
    • Dalby NO  et al. Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1. Epilepsy Res 28:51-61 (1997). Read more (PubMed: 9255599) »

    See 0 Publications for this product

    Product Wall

    There are currently no Questions for ab120317.
    Please use the link above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"